Bivalirudin and ECLS: Commentary and Considerations

Troy G. Seelhammer; John K. Bohman; Devon O. Aganga; Simon Maltais; Yanjun Zhao

doi:10.1097/MAT.0000000000000891

Bivalirudin and ECLS: Commentary and Considerations

Troy G. Seelhammer, John K. Bohman, Devon O. Aganga, Simon Maltais, Yanjun Zhao

Cardiovascular Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E52-E53
Journal	ASAIO Journal
Volume	65
Issue number	5
DOIs	https://doi.org/10.1097/MAT.0000000000000891
State	Published - Jul 1 2019

ASJC Scopus subject areas

Biophysics
Bioengineering
Biomaterials
Biomedical Engineering

Access to Document

10.1097/MAT.0000000000000891

Cite this

@article{511ff47cf3ce4679a26c303afbe53c7d,

title = "Bivalirudin and ECLS: Commentary and Considerations",

author = "Seelhammer, {Troy G.} and Bohman, {John K.} and Aganga, {Devon O.} and Simon Maltais and Yanjun Zhao",

year = "2019",

month = jul,

day = "1",

doi = "10.1097/MAT.0000000000000891",

language = "English (US)",

volume = "65",

pages = "E52--E53",

journal = "ASAIO Journal",

issn = "1058-2916",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Bivalirudin and ECLS

T2 - Commentary and Considerations

AU - Seelhammer, Troy G.

AU - Bohman, John K.

AU - Aganga, Devon O.

AU - Maltais, Simon

AU - Zhao, Yanjun

PY - 2019/7/1

Y1 - 2019/7/1

UR - http://www.scopus.com/inward/record.url?scp=85069268327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069268327&partnerID=8YFLogxK

U2 - 10.1097/MAT.0000000000000891

DO - 10.1097/MAT.0000000000000891

M3 - Letter

C2 - 30299300

AN - SCOPUS:85069268327

SN - 1058-2916

VL - 65

SP - E52-E53

JO - ASAIO Journal

JF - ASAIO Journal

IS - 5

ER -

Bivalirudin and ECLS: Commentary and Considerations

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this